Insufficient scRNA-seq data for expression of SLC52A1 at single-cell level.
Insufficient scRNA-seq data for expression of SLC52A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 56% | 49.49 | 326 / 578 | 71% | 4.22 | 820 / 1155 |
prostate | 87% | 176.65 | 214 / 245 | 26% | 0.53 | 132 / 502 |
bladder | 52% | 148.90 | 11 / 21 | 59% | 3.35 | 299 / 504 |
thymus | 58% | 26.92 | 382 / 653 | 48% | 2.69 | 288 / 605 |
esophagus | 39% | 54.60 | 560 / 1445 | 66% | 4.64 | 120 / 183 |
uterus | 35% | 27.35 | 60 / 170 | 67% | 6.38 | 309 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.64 | 1 / 1 |
breast | 52% | 33.90 | 238 / 459 | 47% | 1.76 | 523 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 98% | 10.24 | 44 / 45 |
spleen | 89% | 59.72 | 214 / 241 | 0% | 0 | 0 / 0 |
skin | 80% | 498.37 | 1456 / 1809 | 6% | 0.15 | 30 / 472 |
intestine | 52% | 304.38 | 499 / 966 | 32% | 0.71 | 167 / 527 |
kidney | 47% | 15.63 | 42 / 89 | 31% | 1.52 | 278 / 901 |
lymph node | 0% | 0 | 0 / 0 | 41% | 2.56 | 12 / 29 |
stomach | 4% | 1.37 | 15 / 359 | 29% | 0.80 | 84 / 286 |
muscle | 30% | 13.73 | 242 / 803 | 0% | 0 | 0 / 0 |
pancreas | 1% | 0.16 | 2 / 328 | 18% | 0.75 | 32 / 178 |
brain | 11% | 3.25 | 281 / 2642 | 5% | 0.11 | 37 / 705 |
ovary | 1% | 0.14 | 1 / 180 | 14% | 0.31 | 60 / 430 |
peripheral blood | 13% | 8.19 | 121 / 929 | 0% | 0 | 0 / 0 |
liver | 2% | 0.98 | 5 / 226 | 4% | 0.13 | 16 / 406 |
adipose | 5% | 2.01 | 57 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 4% | 1.98 | 53 / 1335 | 0% | 0 | 0 / 0 |
heart | 2% | 0.66 | 19 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
adrenal gland | 0% | 0.10 | 1 / 258 | 0% | 0.00 | 1 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0032218 | Biological process | riboflavin transport |
GO_0006771 | Biological process | riboflavin metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0032217 | Molecular function | riboflavin transmembrane transporter activity |
Gene name | SLC52A1 |
Protein name | Solute carrier family 52, riboflavin transporter, member 1 (Porcine endogenous retrovirus A receptor 2) (PERV-A receptor 2) (huPAR-2) (Protein GPR172B) (Riboflavin transporter 1) (hRFT1) Riboflavin transporter |
Synonyms | RFT1 GPR172B PAR2 |
Description | FUNCTION: Plasma membrane transporter mediating the uptake by cells of the water soluble vitamin B2/riboflavin that plays a key role in biochemical oxidation-reduction reactions of the carbohydrate, lipid, and amino acid metabolism . Humans are unable to synthesize vitamin B2/riboflavin and must obtain it via intestinal absorption . .; FUNCTION: (Microbial infection) May function as a cell receptor to retroviral envelopes similar to the porcine endogenous retrovirus (PERV-A). . FUNCTION: Plasma membrane transporter mediating the uptake by cells of the water soluble vitamin B2/riboflavin that plays a key role in biochemical oxidation-reduction reactions of the carbohydrate, lipid, and amino acid metabolism. . |
Accessions | ENST00000424747.1 [Q9NWF4-1] ENST00000512825.7 Q9NWF4 ENST00000254853.10 [Q9NWF4-1] F5H5Y1 |